Developing a framework for regular and sustainable qualitative assessment of antibiotic use in Korean medical institutions : a Delphi study
© 2023. BioMed Central Ltd., part of Springer Nature..
BACKGROUND: We aimed to develop a roadmap for conducting regular, sustainable, and strategic qualitative assessments of antibiotic use in medical institutions within the Republic of Korea.
METHODS: A literature review on the current state of qualitative antibiotic assessments was conducted, followed by one open round to collect ideas, two scoring rounds to establish consensus, and one panel meeting between them. The expert panel comprised 20 experts in infectious disease or antibiotic stewardship.
RESULTS: The response rate for all three surveys was 95% (19/20), while the panel meeting attendance rate was 90% (18/20). The following long-term goals were defined to assess the annual use of antibacterial and antifungal agents in all medical institutions, including clinics. The panel agreed that random sampling of antibiotic prescriptions was the most suitable method of selecting antibiotics for qualitative assessment, with the additional possibility of evaluating specific antibiotics or infectious diseases that warrant closer evaluation for promoting appropriate antibiotic use. The plan for utilization of results from evaluation involves providing feedback while maintaining anonymity and disclosure. It includes a quantitative assessment of antibiotic prescriptions and resistance rates to compare against institutional benchmarks. Furthermore, it was agreed to link the evaluation findings to the national antibiotic stewardship programme, enabling policy and institutional approaches to address frequently misused items, identified during the evaluation.
CONCLUSION: This study provides a framework for establishing a qualitative assessment of antimicrobial use for medical institutions at a national level in the Republic of Korea.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
---|---|
Enthalten in: |
Antimicrobial resistance and infection control - 12(2023), 1 vom: 18. Okt., Seite 114 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Park, Se Yoon [VerfasserIn] |
---|
Links: |
---|
Themen: |
Anti-Bacterial Agents |
---|
Anmerkungen: |
Date Completed 23.10.2023 Date Revised 22.11.2023 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.1186/s13756-023-01319-8 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM363459502 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM363459502 | ||
003 | DE-627 | ||
005 | 20231226093408.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1186/s13756-023-01319-8 |2 doi | |
028 | 5 | 2 | |a pubmed24n1211.xml |
035 | |a (DE-627)NLM363459502 | ||
035 | |a (NLM)37853455 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Park, Se Yoon |e verfasserin |4 aut | |
245 | 1 | 0 | |a Developing a framework for regular and sustainable qualitative assessment of antibiotic use in Korean medical institutions |b a Delphi study |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 23.10.2023 | ||
500 | |a Date Revised 22.11.2023 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2023. BioMed Central Ltd., part of Springer Nature. | ||
520 | |a BACKGROUND: We aimed to develop a roadmap for conducting regular, sustainable, and strategic qualitative assessments of antibiotic use in medical institutions within the Republic of Korea | ||
520 | |a METHODS: A literature review on the current state of qualitative antibiotic assessments was conducted, followed by one open round to collect ideas, two scoring rounds to establish consensus, and one panel meeting between them. The expert panel comprised 20 experts in infectious disease or antibiotic stewardship | ||
520 | |a RESULTS: The response rate for all three surveys was 95% (19/20), while the panel meeting attendance rate was 90% (18/20). The following long-term goals were defined to assess the annual use of antibacterial and antifungal agents in all medical institutions, including clinics. The panel agreed that random sampling of antibiotic prescriptions was the most suitable method of selecting antibiotics for qualitative assessment, with the additional possibility of evaluating specific antibiotics or infectious diseases that warrant closer evaluation for promoting appropriate antibiotic use. The plan for utilization of results from evaluation involves providing feedback while maintaining anonymity and disclosure. It includes a quantitative assessment of antibiotic prescriptions and resistance rates to compare against institutional benchmarks. Furthermore, it was agreed to link the evaluation findings to the national antibiotic stewardship programme, enabling policy and institutional approaches to address frequently misused items, identified during the evaluation | ||
520 | |a CONCLUSION: This study provides a framework for establishing a qualitative assessment of antimicrobial use for medical institutions at a national level in the Republic of Korea | ||
650 | 4 | |a Review | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Antibiotic stewardship | |
650 | 4 | |a Antibiotics | |
650 | 4 | |a Consensus | |
650 | 4 | |a Expert | |
650 | 4 | |a Qualitative assessment | |
650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
650 | 7 | |a Anti-Infective Agents |2 NLM | |
700 | 1 | |a Kim, Yong Chan |e verfasserin |4 aut | |
700 | 1 | |a Moon, Song Mi |e verfasserin |4 aut | |
700 | 1 | |a Kim, Bongyoung |e verfasserin |4 aut | |
700 | 1 | |a Lee, Raeseok |e verfasserin |4 aut | |
700 | 1 | |a Kim, Hong Bin |e verfasserin |4 aut | |
700 | 0 | |a Korea Study Group for Antimicrobial Stewardship (KOSGAP) |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Antimicrobial resistance and infection control |d 2012 |g 12(2023), 1 vom: 18. Okt., Seite 114 |w (DE-627)NLM220841640 |x 2047-2994 |7 nnns |
773 | 1 | 8 | |g volume:12 |g year:2023 |g number:1 |g day:18 |g month:10 |g pages:114 |
856 | 4 | 0 | |u http://dx.doi.org/10.1186/s13756-023-01319-8 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 12 |j 2023 |e 1 |b 18 |c 10 |h 114 |